comparemela.com

Latest Breaking News On - Nir uriel - Page 1 : comparemela.com

THT 2024 Late-Breaking Clinical Science Announced

The complete list of late-breaking clinical science to be presented at THT 2024: Technology and Heart Failure Therapeutics is now available online. An internat

United statesTufts medical centerNew yorkCleveland clinicWilliamt abrahamGabriel sayerDaniel burkhoffDavidm kayeJoann lindenfeldSanjivj shahNavink kapurJerryd estepSeanp pinneyUlrichp jordeSteveno marxAdamb greenbaum

THT 2024 Late-Breaking Clinical Science Announced

The complete list of late-breaking clinical science to be presented at THT 2024: Technology and Heart Failure Therapeutics is now available online. An internat

United statesNew yorkTufts medical centerCleveland clinicLiviu kleinFiras zahrWh wilson tangKanikap modyStavrosg drakosSnehalr patelKamile cerlinskaite bajoreSitaramesh emaniNir urielDavid ian feldmanDeya alkhatibDaniel burkhoff

Big Step Forward for Transcatheter Tricuspid Valve Replacement: TRISCEND II

TR was eliminated, safety looked good, and symptoms improved all good news for hard-to-treat patients, say experts.

New yorkUnited statesTown hallSuzanne arnoldRoxana mehranEvoque edwards lifesciencesSusheel kodaliTriclip abbottSam dawkinsNir urielWayne batchelorNeil famDrug administrationMd saint luke mid america heart instituteMd university of toronto stVascular institute

First U S Patients Implanted with Innovative FIRE1 Remote Heart Failure Monitoring System in Early Feasibility Study

FIRE1 announced the start of the first U.S. clinical study of its remote heart failure monitoring system, designed to provide unique insights to the care team and alert to deteriorating patient conditions for the almost 10M Americans with HF

New yorkUnited statesHeart hospital of austinNir urielConor hanleyThomas mcminnKunjan bhattNational principal investigatorEarly feasibilityAustin heartPrincipal investigatorHeart hospitalHeart failureHeart transplantMechanical circulatory supportColumbia university vagelos college

Impulse Dynamics Announces First Implant for CCM-D Clinical Trial

World's First Device Combining CCM Therapy With an ICD in a Single Rechargeable Implant That Treats Both Heart Failure Symptoms and Sudden Cardiac DeathMARLTON, N.J., May 18, 2023 (GLOBE NEWSWIRE) Impulse

United statesNew yorkSimos kedikoglouNir urielBruce wilkoffGewinn nurNiraj varmaNational primary investigatorNational coDrug administrationColumbia university vagelos college of physiciansFirst device combiningSudden cardiacOptimizer systemOptimizer integraCleveland clinic

vimarsana © 2020. All Rights Reserved.